from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2588c/yajC

LFCtreatmentdescriptionclass of inhibitor

0.652

Amikacinug/mL Amikacintranslation

1.291

Cap5-10ug/mL Capreomycintranslation

2.229

Rox10-50 ug/mL Roxithromycintranslation

-0.106

SM2-5 ug/mL Streptomycintranslation

1.508

Tet5-10 ug/mL Tetracyclinetranslation

-0.667

Rif0.2-5ug/mL Rifampicintranscription

-0.543

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.154

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.985

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.682

CPZ10-50 ug/mL Chlorpromazinerespiration

0.334

Clofazimine10-13 ug/mL Clofaziminerespiration

0.309

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.845

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.197

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.447

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.320

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.207

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.937

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.364

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.878

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.777

KCN5-20 ug/mL Potassium cyaniderespiration

0.169

NaN30.2-2 mM Sodium aziderespiration

0.460

Nigericin50 uM Nigericinrespiration

-1.087

TRC10-150 ug/mL Triclosanrespiration

-1.009

TRZ10-25 ug/mL Thioridazinerespiration

-1.047

Valinomycin0.5-10 uM Valinomycinrespiration

0.445

ZnSO42 mM ZnSO4respiration

0.816

menadione6-10 ug/mL Menadionerespiration

0.273

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.133

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.068

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.462

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.307

NRP_1Non-replicating persistence stage 1dosRassociated

0.856

Amp0.2mg/mL AmpicillincellWall

0.071

Cephalexin20-100 ug/mL CephalexincellWall

0.272

Cerulenin0.32-5 ug/mL CerulenincellWall

0.408

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.372

EMB10-20 ug/mL EthambutolcellWall

0.457

Eta12-40 ug/mL EthionamidecellWall

-0.061

INH0.2-0.4 ug/mL IsoniazidcellWall

0.802

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.067

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.425

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.521

BZA0.12 mg/mL BenzamidearomaticAmides

-0.349

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.759

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.382

H2O24 mM hydrogen peroxideDNAdamaging

0.558

Levo10 ug/mL LevofloxacinDNAdamaging

0.380

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.819

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.826

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.089

UVUV-irradiationDNAdamaging

-1.340

ARP41-4 ug/mL Antitubercular compound ARP4?

0.005

Antimycin12.5-50 ug/mL Antimycin A?

0.511

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.043

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.457

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.781

PA8240.2-2 ug/mL PA-824?

-0.846

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.215

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.246

Verapamil50 uM Verapamil?

0.493

mercaptoethanol2 mM 2-Mercaptoethanol?

0.175

methoxatin10-20 ug/mL Methoxatin?